Founding Partner
The U.S. Food and Drug Administration (FDA) has issued an early alert regarding the Baxter Novum IQ Large Volume Pump (LVP) following reports of serious injuries and patient deaths linked to device malfunctions. The infusion pump, widely used in hospitals across the country, is intended to deliver intravenous fluids, medications, and blood products under physician supervision. However, the device has shown a potentially dangerous defect that can cause underinfusion, overinfusion, or total non-delivery of critical medications, posing life-threatening risks to patients.
Baxter has acknowledged receiving at least 79 reports of serious injuries and two deaths associated with this defect. These alarming statistics have prompted a nationwide call for urgent action to protect patient safety.
The affected product, Baxter’s Novum IQ Large Volume Pump, has been flagged for problems during infusion rate changes, particularly when transitioning to a flow rate that is more than double the previous rate. The malfunction may result in partial or complete failure to deliver prescribed treatments, leading to hemodynamic instability, cardiac arrhythmias, insufficient sedation, hyperglycemia, or thromboembolic events.
Additionally, Baxter identified increased reports of incorrect loading of the administration set, which can cause dangerous variations in infusion rates. The recall affects all units under product code 40700BAXUS (UDI-DI 05413765851797) currently in use nationwide.
Hospitals have been instructed to change administration sets or replace affected pumps as soon as it is safe to do so. When immediate replacement isn’t possible, specific steps must be followed to reduce risk, but these measures do not eliminate the underlying defect.
Patients rely on infusion pumps for precise, life-saving drug delivery during hospitalization. A malfunction can have devastating consequences, especially for critically ill patients or those undergoing complex treatments. Known risks include:
Families affected by pump malfunctions may experience unexpected medical complications, additional hospitalization, long-term health consequences, or the loss of a loved one.
Medical device manufacturers are legally obligated to ensure the safety of their products before they are introduced into patient care. If a defective device causes harm, patients and their families may have grounds to pursue legal claims against Baxter for:
Holding manufacturers accountable not only provides justice for victims but also helps improve patient safety standards nationwide.
If you or someone close to you suffered complications linked to a Baxter Novum IQ infusion pump, take these steps immediately:
Prompt legal action can preserve evidence and strengthen your case against negligent medical device manufacturers.
If you or a loved one experienced complications due to a defective Baxter Novum IQ infusion pump, you may be entitled to financial compensation. Parker Waichman LLP is a national personal injury law firm with extensive experience in defective medical device claims.
Call 1-800-YOUR-LAWYER (1-800-968-7529) now for a free consultation to protect your rights and seek justice for the harm you’ve suffered. Regardless of your location or where your injury occurred, our nationwide product injury law firmis ready to assist you and provide a free consultation.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
We handle mass torts cases nationwide. Please contact our office to learn more.